European Foundation for the Study of Chronic Liver Failure
- Research works
- 77 ▲ 349% vs 2013–17
- Citations
- 2.7k 34.8 per fractional work
- Top-10% rate
- 34.4% record average 16.5%
- Open access
- 62% world 28%
Not ranked overall: European Foundation for the Study of Chronic Liver Failure is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does European Foundation for the Study of Chronic Liver Failure specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.3× the share of its output that it takes of world research.
- MedicineField · 24.2 works4.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 12.0×
- Nursing 5.1×
- Medicine 4.3×
- Immunology and Microbiology 2.2×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Agricultural and Biological Sciences 0.2×
- Mathematics 0.2×
- Neuroscience 0.1×
- Chemistry 0.1×
- Business, Management and Accounting 0.1×
- Physics and Astronomy 0.1×
- Decision Sciences 0.1×
- Engineering 0.0×
- Environmental Science 0.0×
Who are the top researchers at European Foundation for the Study of Chronic Liver Failure?
Ranked on the composite score, Maximilian Joseph Brol and Robert Schierwagen lead among researchers whose main affiliation is European Foundation for the Study of Chronic Liver Failure.
- 1 Maximilian Joseph Brol Spain · #526,974 worldwide 35 citations · 18 works
- 2 Robert Schierwagen Spain · #561,294 worldwide 120 citations · 59 works
Which keywords describe research at European Foundation for the Study of Chronic Liver Failure?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Coagulopathy, Hepatic Encephalopathy, Liver Cirrhosis, Metabolic Syndrome, Hepatocellular Carcinoma, Insulin Resistance, NAFLD and NASH.
- Cardiovascular Disease
- Liver Disease
- Infection
- Drug-Induced Liver Injury
- Mitochondrial Dysfunction
- Ischemia-Reperfusion Injury
- Graft Survival
- Biomarkers
- Inflammation
- NASH
- Insulin Resistance
- Hepatocellular Carcinoma
- Hepatic Encephalopathy
- Coagulopathy
- Liver Cirrhosis
- Metabolic Syndrome
- NAFLD
- Liver Transplantation
- Oxidative Stress
- Epidemiology
- Donor Risk Index
- Critical Care
- Antioxidants
- Hepatotoxicity
- Management
- Sepsis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 26 words, with their numbers
- Coagulopathy7▲ 317×2 topics
- Hepatic Encephalopathy7▲ 443×1 topic
- Liver Cirrhosis7▲ 443×1 topic
- Hepatocellular Carcinoma6▲ 101×3 topics
- Metabolic Syndrome6▲ 26×4 topics
- Insulin Resistance6▲ 45×4 topics
- NAFLD6▲ 169×1 topic
- NASH6▲ 169×1 topic
- Liver Transplantation4▲ 107×4 topics
- Inflammation3▲ 5.1×25 topics
- Oxidative Stress3▲ 6.1×13 topics
- Biomarkers2▲ 12×7 topics
- Epidemiology2▲ 1.97×16 topics
- Graft Survival2▲ 87×2 topics
- Donor Risk Index2▲ 167×1 topic
- Ischemia-Reperfusion Injury2▲ 107×1 topic
- Critical Care2▲ 22×3 topics
- Mitochondrial Dysfunction2▲ 17×3 topics
- Antioxidants1▲ 9.7×2 topics
- Drug-Induced Liver Injury1▲ 149×1 topic
- Hepatotoxicity1▲ 86×1 topic
- Infection1▲ 16×6 topics
- Management1▲ 5.3×3 topics
- Liver Disease1▲ 40×3 topics
- Sepsis1▲ 23×4 topics
- Cardiovascular Disease1▲ 3.2×8 topics
Which research topics does European Foundation for the Study of Chronic Liver Failure publish most on?
By volume in 2022–2025: Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Organ Transplantation Techniques and Outcomes and Drug-Induced Hepatotoxicity and Protection.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Liver Disease and Transplantation Hepatology 7 works
- 2 Liver Disease Diagnosis and Treatment Epidemiology 6 works
- 3 Organ Transplantation Techniques and Outcomes Surgery 2 works
- 4 Drug-Induced Hepatotoxicity and Protection Pharmacology 1 works
- 5 Alcohol Consumption and Health Effects Pathology and Forensic Medicine 1 works
- 6 Clinical Nutrition and Gastroenterology Nutrition and Dietetics 1 works
- 7 Sepsis Diagnosis and Treatment Epidemiology 1 works
- 8 Nutrition and Health in Aging Physiology 0 works
- 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 10 Chronic Kidney Disease and Diabetes Nephrology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has European Foundation for the Study of Chronic Liver Failure's research output changed?
Output in 2018–2022 was 349% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Barcelona
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Hospital Clínic de Barcelona
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.